[HTML][HTML] Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies

K Dhama, F Nainu, A Frediansyah, MI Yatoo… - Journal of infection and …, 2023 - Elsevier
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are continuously posing high global public health concerns and panic resulting in waves of …

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges

K Dhama, M Dhawan, R Tiwari, TB Emran… - Human vaccines & …, 2022 - Taylor & Francis
Multiple vaccines have recently been developed, and almost all the countries are presently
vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 …

Medicinal plants, phytochemicals, and herbs to combat viral pathogens including SARS-CoV-2

AV Anand, B Balamuralikrishnan, M Kaviya, K Bharathi… - Molecules, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome corona virus-2 (SARS-CoV-2), is the most important health issue, internationally …

Egypt's COVID-19 recent happenings and perspectives: a mini-review

ARA Saied, AA Metwally, NAB Madkhali… - Frontiers in Public …, 2021 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected countries across the world. While the …

[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19

K Sharun, R Tiwari, MI Yatoo, S Natesan, D Megawati… - Narra J, 2022 - ncbi.nlm.nih.gov
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …

[HTML][HTML] SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review

R Kumar, CM Yeni, NA Utami, R Masand… - Journal of Infection and …, 2021 - Elsevier
The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health problem. The …

Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine …

AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

AA Rabaan, SH Al-Ahmed, R Sah, R Tiwari… - Annals of Clinical …, 2020 - Springer
A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19),
first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with …

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

K Dhama, S Natesan, M Iqbal Yatoo… - Human Vaccines & …, 2020 - Taylor & Francis
Globally, researchers are undertaking significant efforts to design and develop effective
vaccines, therapeutics, and antiviral drugs to curb the spread of coronavirus disease 2019 …

COVID-19 in the elderly people and advances in vaccination approaches

K Dhama, SK Patel, S Natesan, KS Vora… - Human vaccines & …, 2020 - Taylor & Francis
The rapid worldwide spread of the COVID-19 pandemic, caused by the newly emerged
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in tens of …